Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

R Ehehalt, M Esteve, K Katsanos… - Journal of Crohn's …, 2014 - academic.oup.com
6.1. Background The incidence of tuberculosis (TB) is a concern at the start of the third
millennium, particularly with the increase of multiresistant (MDR-TB) and extended resistant …
被引用次数：1038 相关文章
[PDF] stge.org.tn

[PDF][PDF] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's and …, 2014 - stge.org.tn
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators. With such immunomodulation, the …

[引用][C] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's and …, 2014 - cir.nii.ac.jp
Second European evidence-based consensus on the prevention, diagnosis and management
of opportunistic infections in inflammatory bowel disease | CiNii Research CiNii 国立情報学 …

[引用][C] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's & …, 2014 - europepmc.org
Second European evidence-based consensus on the prevention, diagnosis and
management of opportunistic infections in inflammatory bowel disease. - Abstract - Europe …
[PDF] skreyweb.com

[PDF][PDF] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi, S Ben-Horin… - minio-prod.skreyweb.com
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators. With such immunomodulation, the …

[引用][C] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

J Rahier, F Magro, J Abreu, A Armuzzi… - Journal of Crohn's and …, 2014 - repub.eur.nl
RePub, Erasmus University Repository: Second European evidence-based consensus on the
prevention, diagnosis and management of opportunistic infections in inflammatory bowel …
[PDF] core.ac.uk

[PDF][PDF] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's and …, 2014 - core.ac.uk
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators. With such immunomodulation, the …
[PDF] researchgate.net

[PDF][PDF] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's …, 2014 - researchgate.net
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators. With such immunomodulation, the …
[PDF] ed.ac.uk

[PDF][PDF] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's …, 2014 - research.ed.ac.uk
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators. With such immunomodulation, the …
[PDF] academia.edu

[PDF][PDF] Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

JF Rahier, F Magro, C Abreu, A Armuzzi… - Journal of Crohn's and …, 2014 - academia.edu
The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past
decade by the increasing use of immunomodulators. With such immunomodulation, the …